Risk factors and clinical outcomes associated with mitral annular calcification in hypertrophic obstructive cardiomyopathy: a retrospective analysis
Expert Review of Clinical Pharmacology · 2026
DOI: 10.1080/17512433.2026.2619131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Expert Review of Clinical Pharmacology, 2026. Verfasst von Bowen Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Calcinosis, Mitral Valve, Septal Myectomy. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to identify risk factors associated with mitral annular calcification (MAC) in patients with hypertrophic obstructive cardiomyopathy (HOCM) and to evaluate its relationship with clinical outcomes. METHODS: A total of 310 patients with HOCM who underwent interventricular septal myectomy were retrospectively analyzed. Patients were divided into a MAC group (n = 24) and a non-MAC group (n = 286). Demographic characteristics, echocardiographic parameters, and clinical data were compared between groups. Major adverse cardiovascular and cerebrovascular event (MACCE) and circulating levels of brain natriuretic peptide, Apelin, and Galectin-3 were analyzed. RESULTS: Patients with MAC were older and showed higher prevalence of aortic annular calcification, mitral leaflet thickening, and moderate-to-severe tricuspid regurgitation (P < 0.05). Multivariate analysis identified gender, age, aortic annular calcification, moderate-to-severe tricuspid regurgitation, and mitral leaflet thickening as independent risk factors for MAC. Patients with MAC showed larger left ventricular end-diastolic volume, reduced left ventricular ejection fraction, and greater left atrium mass, and a higher incidence of MACCE than those without MAC (P < 0.05). CONCLUSION: In HOCM undergoing septal myectomy, MAC is associated with adverse cardiac remodeling and unfavorable clinical outcomes. Identification of related factors may aid risk stratification and perioperative management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
Zitieren
APA
Guo, B., Song, B., Xu, X., Dang, H., & Dong, R. (2026). Risk factors and clinical outcomes associated with mitral annular calcification in hypertrophic obstructive cardiomyopathy: a retrospective analysis. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2619131
Vancouver
Guo B, Song B, Xu X, Dang H, Dong R. Risk factors and clinical outcomes associated with mitral annular calcification in hypertrophic obstructive cardiomyopathy: a retrospective analysis. Expert Review of Clinical Pharmacology. 2026. doi:10.1080/17512433.2026.2619131
BibTeX
@article{Guo2026,
author = {Guo, Bowen and Song, Bangrong and Xu, Xiaoyu and Dang, Haiming and Dong, Ran},
title = {Risk factors and clinical outcomes associated with mitral annular calcification in hypertrophic obstructive cardiomyopathy: a retrospective analysis},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
doi = {10.1080/17512433.2026.2619131}
}
EUVIMED